LLS:
LEADING
PRECISION
MEDICINE.
The Leukemia & Lymphoma Society is leading the charge
against one of the most daunting challenges in blood cancer:
acute myeloid leukemia (AML), which claims the lives of nearly
11 ,000 patients in the U.S. each year. Our groundbreaking
Beat AML® Master Clinical Trial brings together the brightest
minds across the cancer landscape. Using a precision medicine
approach to treatment, patients are assigned a targeted therapy
based on their genetic profi le.To bring new and better treatments to cancer patients in
urgent need, we need to think and act boldly.LEADING
Please help us by
donating today at